Immuneering Corporation Announces Grants of Inducement Awards
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation NASDAQ:IMRX, a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, previously announced on June 15, 2026, that Andrew Gengos was named Chief Financial Officer of the Company, effec…